Marginal Treatment Benefit in Anaplastic Thyroid CancerHAYMART, Megan R; BANERJEE, Mousumi; HUIYING YIN et al.Cancer. 2013, Vol 119, Num 17, pp 3133-3139, issn 0008-543X, 7 p.Article

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological informationMONTERO-CONDE, C; MARTIN-CAMPOS, J. M; ROBLEDO, M et al.Oncogene (Basingstoke). 2008, Vol 27, Num 11, pp 1554-1561, issn 0950-9232, 8 p.Article

Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancerAKAISHI, Junko; ONDA, Masamitsu; ASAKA, Shinichi et al.Anticancer research. 2006, Vol 26, Num 6B, pp 4437-4442, issn 0250-7005, 6 p.Article

Metastatic anaplastic carcinoma of the thyroid mimicking squamous cell carcinoma : Report of a case of a challenging cytologic diagnosisOKTAY, Maja H; SMOLKIN, Matthew B; WILLIAMS, Mark et al.Acta cytologica. 2006, Vol 50, Num 2, pp 201-204, issn 0001-5547, 4 p.Article

Thyroid cancer review 3 : management of medullary and undifferentiated thyroid cancerNIX, P. A; NICOLAIDES, A; COATESWORTH, A. P et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 1, pp 80-84, issn 1368-5031, 5 p.Article

Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovory of its expression inhibits cell growthONDA, M; AKAISHI, J; ASAKA, S et al.British journal of cancer. 2005, Vol 92, Num 12, pp 2216-2224, issn 0007-0920, 9 p.Article

Anaplastic thyroid cancerO'NEILL, James Paul; SHAHA, Ashok R.Oral oncology (1997). 2013, Vol 49, Num 7, pp 702-706, issn 1368-8375, 5 p.Article

ACR Appropriateness Criteria^® thyroid carcinomaSALAMA, Joseph K; GOLDEN, Daniel W; WORDEN, Francis et al.Oral oncology (1997). 2014, Vol 50, Num 6, pp 577-586, issn 1368-8375, 10 p.Article

Radioiodide imaging and treatment of ARO cancer xenograft in a mousel model after expression of human sodium iodide symporterHSIEH, Ya-Ju; KE, Chien-Chih; LIU, Ren-Shyan et al.Anticancer research. 2007, Vol 27, Num 4B, pp 2515-2522, issn 0250-7005, 8 p.Article

Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancerAKAISHI, J; ONDA, M; OKAMOTO, J et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 4, pp 213-218, issn 0171-5216, 6 p.Article

Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystinTAE HYUN KIM; YOUNG HYUN YOO; KANG, Do-Young et al.International journal of oncology. 2009, Vol 34, Num 5, pp 1353-1362, issn 1019-6439, 10 p.Article

Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinomaWISEMAN, Sam M; GRIFFITH, Obi L; GOWN, Allen et al.The American journal of surgery. 2011, Vol 201, Num 5, pp 578-584, issn 0002-9610, 7 p.Conference Paper

Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinomaWISEMAN, Sam M; GRIFFITH, Obi L; GOWN, Allen et al.The American journal of surgery. 2011, Vol 201, Num 5A, pp 580-586, issn 0002-9610, 7 p.Article

A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancersCOHEN, Stephanie M; MUKERJI, Ridhwi; TIMMERMANN, Barbara N et al.The American journal of surgery. 2012, Vol 204, Num 6, pp 895-900, issn 0002-9610, 6 p.Article

Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathwayZHONG, Wen-Bin; HSU, Sung-Po; HO, Pei-Yin et al.Biochemical pharmacology. 2011, Vol 82, Num 11, pp 1663-1672, issn 0006-2952, 10 p.Article

Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinomaPRICHARD, Christopher N; KIM, Seungwon; YAZICI, Yasmin D et al.The Laryngoscope. 2007, Vol 117, Num 4, pp 674-679, issn 0023-852X, 6 p.Article